Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. - Wikidata - wikimedia - TriplyDB

Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.

Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.

http://www.wikidata.org/entity/Q37372180

about

Optimal usage of the GnRH antagonists: a review of the literature Cabergoline for preventing ovarian hyperstimulation syndrome Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization.The Impact of Pituitary Blockage with GnRH Antagonist and Gonadotrophin Stimulation Length on The Outcome of ICSI Cycles in Women Older than 36 Years Mild ovarian stimulation for IVF: 10 years later.A new approach for ovarian stimulation in IVF using Corifollitropin Alfa in combination with GnRH analogues to trigger final oocyte maturation. A pilot study Comparison of hCG triggering versus hCG in combination with a GnRH agonist: a prospective randomized controlled trial.Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran.Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre, Japanese cohort Does the degree of hypothalamic-pituitary-ovarian recovery after oral contraceptive pills affect outcomes of IVF/ICSI cycles receiving GnRH-antagonist adjuvant therapy in women over 35 years of age?Pretreatment with oral contraceptive pills to identify poor responders that may benefit from rLH supplementation during GnRH-antagonist treatment for IVF: A pilot perspective study proposal.Corifollitropin stimulation in combination with GnRH-antagonists after estradiol valerate pre-treatment. A pilot study on patientfriendly IVF.Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial.Observational Study to Assess the Therapeutic Value of Four Ovarian Hyperstimulation Protocols in IVF After Pituitary Suppression with GnRH Antagonists in Normally Responding Women.GnRH antagonist, cetrorelix, for pituitary suppression in modern, patient-friendly assisted reproductive technology.Should mild stimulation be the order of the day?Optimisation of the follicular phase in IVF/ICSI Fertility preservation in girls and young women.The impact of the time interval on in-vitro fertilisation success after failure of the first attempt.Assessing predictors for the success of GnRH antagonist protocol in reproductive women in IVF/ICSI - in fresh cycles.Scheduling GnRH antagonist cycles by a short course of oral estradiol administration during early follicular phase: a comparative study with non-scheduled cycles.The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity.Timing of human chorionic gonadotrophin (hCG) hormone administration in IVF protocols using GnRH antagonists: a randomized controlled trial.A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates.Gene expression profile in the endometrium on the day of oocyte retrieval after ovarian stimulation with low-dose hCG in the follicular phase.Dual trigger of triptorelin and HCG optimizes clinical outcome for high ovarian responder in GnRH-antagonist protocols.Comparison between the gonadotropin-releasing hormone antagonist protocol and the gonadotropin-releasing hormone agonist long protocol for controlled ovarian hyperstimulation in the first in vitro fertilization-embryo transfer cycle in an unspecifie Ovarian Hyperstimulation Syndrome: A Narrative Review of Its Pathophysiology, Risk Factors, Prevention, Classification, and Management.

P2860

Q21245566-BFDC6D30-9DD5-4BF1-87D7-32AE4E31D559 Q24203638-A4230E2B-B011-462F-BE0A-2449E409F91D Q30399747-5C8DA10A-AFA1-4071-8DE9-EC8B32E0C294 Q33937249-47B6E197-34D9-4FCE-8F98-370EAE7670E3 Q34139320-AACFB162-AEBC-4829-A134-36B0810F08CC Q34439774-6174A295-4B2D-4B07-9BC1-897267320474 Q34866439-FFED8D55-5616-4A18-BDA7-6CA6508DAA07 Q35808082-F9D0AC3F-3003-4F35-B4A1-7406745BDC49 Q36074736-82B34BCA-8897-40F4-8853-0573F3323543 Q36124732-5C8A8C2D-5B0C-4E21-ABB8-C36FAA6D1FD5 Q36295620-0BD387E2-1F52-4195-9A9D-81D2B5A7B1B3 Q36335451-BB6B07BF-1BB2-4BAA-889D-B522F07B3FD8 Q37326952-E106B5B7-8FE5-44CC-9E95-1522A2C47AAE Q37362092-7BCF156A-5F53-4FEC-9171-3D298F252A7D Q37463040-405EB091-39F1-4530-8CCE-FB09D371F257 Q37598922-410CDA9B-B1C7-4CBE-AB10-9A4E9227D435 Q37658023-BEB07DAE-62DB-4A52-9D9A-437B252E6B0B Q37709779-83904FE8-EB4E-4448-A036-B8CA01C857F4 Q37875896-ED202903-3DC3-4DE1-8321-854403EE929D Q45769769-A50F0E8A-F0F7-45F6-A208-D5FA838203AA Q47135497-49CBA3C1-BF04-4D0A-8A2B-20D5777D42F3 Q48578488-23AC37D1-FFBC-4C42-8407-09B9FC0477E3 Q48604738-266AC7B8-41BB-4AF5-81ED-D72589CC89B9 Q48643865-1E95F383-861F-4A5A-B73F-5A1A8DBA329C Q48653009-DEC86D9B-95C7-4551-A42B-F4030B151E26 Q48693072-FF6EF5FF-E135-485E-BA93-8E82AF45F3B5 Q49419476-3B2D72DD-38D9-4E34-A5F5-64914F4CAFD9 Q55257463-3BB47039-E299-4A45-A4AF-90F4DD6C8EED Q55279761-32FE3266-EC6F-41ED-84C4-5290353CB84E

P2860

Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.

http://www.wikidata.org/entity/Q37372180

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Improving the patient's experi ...... GnRH antagonist co-treatment.

@en

Improving the patient's experi ...... GnRH antagonist co-treatment.

@nl

type

label

Improving the patient's experi ...... GnRH antagonist co-treatment.

@en

Improving the patient's experi ...... GnRH antagonist co-treatment.

@nl

prefLabel

Improving the patient's experi ...... GnRH antagonist co-treatment.

@en

Improving the patient's experi ...... GnRH antagonist co-treatment.

@nl

P1433

Q37372180-A8A55C6F-01E8-4827-BACC-563E0768B6AA

P1476

Q37372180-737D20F2-A89C-4913-A546-DE4F56A24592

P2093

Q37372180-1AF4FB6D-75D8-4A1A-98B9-0C277C1F3070

Q37372180-69DF6EF4-2763-43A9-A27C-90EDBFAB2D35

Q37372180-8B8BE141-F815-4D11-80DC-72FEB60B47AA

Q37372180-ABEF80B2-1EF4-4578-B7C1-3E276EB82286

Q37372180-EDCB47C2-0C5C-4857-A4E0-3401B1EC025D

Q37372180-F84B7CFE-C913-46CC-9B97-00970949A6BD

P2860

Q37372180-01D372B5-F5E7-4DE6-BF81-AFA75B568F24

Q37372180-020F4D5F-F1A8-46A0-A826-EB6B761D5A19

Q37372180-06B1D71D-95A4-403C-B0A1-F5240F5CEB80

Q37372180-0ABE100D-F483-4997-A1FA-938A0A5BF68D

Q37372180-0AEBCF36-7E58-479F-B280-BB3B51BB9537

Q37372180-120EA0A5-5E08-44DF-A6CC-B6B8A6195A5F

Q37372180-2AE1A466-0EB1-4170-8F44-E650E4B3EC76

Q37372180-2B5BABDF-36DD-439E-BA46-370BE3077C6C

Q37372180-2E8D50D0-F7D8-445E-B229-5DF23D947C1A

Q37372180-339682F3-DCD0-444D-9B3F-118DE2816805

P304

Q37372180-3E12BDF9-BBA5-4CBB-AC41-F8BF79F42B24

P31

Q37372180-A8F2459E-73BE-4B2F-A567-79B81E1C1E78

P356

Q37372180-BD6F72A5-D9D0-4465-A90B-1E9F768F0353

P407

Q37372180-A16521FA-82B3-4DA4-824A-499077F5120C

P433

Q37372180-97C9319A-14A2-4115-B296-716346F1E869

P478

Q37372180-41FE7381-3D75-4B29-9BD3-CD9CF1DB0D00

P50

Q37372180-5D9A628B-9105-4FB2-9558-BF3525AE1709

Q37372180-81522AEA-E236-4A5F-940A-BDE1E696873B

Q37372180-F62FCE33-21E5-4115-9F71-95F40C8A210E

P577

Q37372180-8F0CAACF-0E88-4E0A-A157-28A10C9E86D2

P5875

Q37372180-12627CE9-E7B3-4ED3-AE50-BC2B8395C1B6

P698

Q37372180-2E085105-23AD-41E2-9F57-0B3A32473999

P356

P1433

Human Reproduction

P1476

Improving the patient's experi ...... GnRH antagonist co-treatment.

@en

P2093

Bart C J M Fauser

http://www.w3.org/2001/XMLSchema#string

Candido Tomás

http://www.w3.org/2001/XMLSchema#string

Efstratios Kolibianakis

http://www.w3.org/2001/XMLSchema#string

Georg Griesinger

http://www.w3.org/2001/XMLSchema#string

Juan Garcia-Velasco

http://www.w3.org/2001/XMLSchema#string

Mohamed Aboulghar

http://www.w3.org/2001/XMLSchema#string

P2860

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry.

Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation.

Progesterone supplementation during early gestation after in vitro fertilization has no effect on the delivery rate.

GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis.

A prospective study of stress among women undergoing in vitro fertilization or gamete intrafallopian transfer.

Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact.

Women's emotional adjustment to IVF: a systematic review of 25 years of research.

Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome.

Psychological impact of infertility.

P304

764-774

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HUMREP/DEN468

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23800806

http://www.w3.org/2001/XMLSchema#string

P698

19153090

http://www.w3.org/2001/XMLSchema#string